Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma (Q66345944)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma
clinical trial

    Statements

    short name
    RESORCE (English)
    0 references
    title
    A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib (English)
    0 references
    country
    Argentina
    0 references
    Australia
    0 references
    Austria
    0 references
    Belgium
    0 references
    Brazil
    0 references
    France
    0 references
    Germany
    0 references
    Hungary
    0 references
    Italy
    0 references
    Japan
    0 references
    Netherlands
    0 references
    Singapore
    0 references
    Spain
    0 references
    Switzerland
    0 references
    Taiwan
    0 references
    United Kingdom
    0 references
    start time
    14 May 2013
    0 references
    end time
    29 February 2016
    0 references
    number of participants
    573
    0 references
    minimum age
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q66345944&oldid=2237185337"